furosemide (Compound)

Synonyms:furosemide, 54-31-9, Frusemide, Lasix, Furanthril, Furosemid, Errolon, Fusid, Aisemide, Beronald, Desdemin, Frusemin, Fuluvamide, Furanthryl, Furantril, Fursemide, Lowpstron, Macasirool, Prefemin, Rosemide, Trofurit, Fulsix, Furesis, Katlex, Lasilix, Radonna, Seguril, Transit, Lasex, Salix, Urex, Marsemide, Eutensin, Frusetic, Fursemid, Logirene, Oedemex, Promedes, Frusid, Lazix, Mirfat, Frusemid, Frusenex, Furanturil, Furosedon, Profemin, Urosemide, Aluzine, Diural, Dryptal, Impugan, Nicorol, Rusyde, Uremide, Uresix, Yidoli, Disal, Laxur, Urian, Apo-Frusemide, Hydro-rapid, Anfuramaide, Arasemide, Bioretic, Disemide, Diurapid, Diurolasa, Diusemide, Durafurid, Fluidrol, Frusedan, Fuluvamine, Furobeta, Furodiurol, Furodrix, Furorese, Furosemidum, Furosemix, Furoside, Furosifar, Furovite, Fursemida, Hissuflux, Hydroled, Jenafusid, Lasiletten, Lowpston, Moilarorin, Novosemide, Protargen, Radisemide, Selectofur, Sigasalur, Spirofur, Synephron, Zafimida, Aldalix, Aquarid, Aquasin, Cetasix, Dirine, Discoid, Diurin, Diusil, Diuzol, Dranex, Edemid, Edenol, Endural, Farsix, Franyl, Frumex, Frumide, Frusema, Furetic, Furfan, Furmid, Furocot, Furomen, Furomex, Furosan, Furose, Furosix, Furoter, Fursol, Hydrex, Kofuzon, Kolkin, Kutrix, Lasemid, Liside, Luscek, Nelsix, Odemase, Odemex, Promide, Puresis, Radouna, Salinex, Salurex, Salurid, Uridon, Uritol, Aldic, Depix, Desal, Eliur, Fluss, Furex, Furix, Golan, Hydro, Nadis, Retep, Rosis, Vesix, Mita, Apo-Furosemide, Furo-puren, Lasix Retard, 4-Chloro-N-furfuryl-5-sulfamoylanthranilic acid, less Diur, Neo-renal, Furo-Basan, Furosemidu, Urex-M, Nephron, Furomide M.D., Furosemida, 4-Chloro-N-(2-furylmethyl)-5-sulfamoylanthranilic acid, LB 502, 5-(Aminosulfonyl)-4-chloro-2-[(2-furylmethyl)amino]benzoic acid, 2-Furfurylamino-4-chloro-5-sulfamoylbenzoic acid, LB-502, NCI-C55936, Lasix (TN), Benzoic acid, 5-(aminosulfonyl)-4-chloro-2-[(2-furanylmethyl)amino]-, Diumide-K, 4-Chloro-5-sulfamoyl-N-furfuryl-anthranilic acid, 4-chloro-2-(furan-2-ylmethylamino)-5-sulfamoylbenzoic acid, 4-chloro-2-[(furan-2-ylmethyl)amino]-5-sulfamoylbenzoic acid, Chlor-N-(2-furylmethyl)-5-sulfamylanthranilsaeure, Anthranilic acid, 4-chloro-N-furfuryl-5-sulfamoyl-, CHEMBL35, 4-Chloro-2-((furan-2-ylmethyl)amino)-5-sulfamoylbenzoic acid, NSC-269420, Benzoic acid, 5-(aminosulfonyl)-4-chloro-2-((2-furanylmethyl)amino)-, 7LXU5N7ZO5, DTXSID6020648, CHEBI:47426, Furosemidu [Polish], 5-(Aminosulfonyl)-4-chloro-2-((2-furanylmethyl)amino)benzoic acid, 5-(Aminosulfonyl)-4-chloro-2-[(2-furanylmethyl)amino]benzoic acid, CAS-54-31-9, Furosemidum [INN-Latin], Furosemida [INN-Spanish], NCGC00016241-06, Sal diureticum, Furosemide "mita", FUN, DTXCID80648, Furosemide mita, Furosemide oral, 4-chloro-2-{[(furan-2-yl)methyl]amino}-5-sulfamoylbenzoic acid, 4-CHLORO-N-FURFURYL-5-SULFAMOYLANTHRANILIC ACID pound>>Furosemide, 5-(Aminosulfonyl)-4-chloro-2-([2-furanylmethyl]amino)benzoic acid, 5-(aminosulfonyl)-4-chloro-2-[(furan-2-ylmethyl)amino]benzoic acid, SMR000058202, CCRIS 1951, furosemide ''mita'', HSDB 3086, SR-01000765380, EINECS 200-203-6, Hoe-058A, UNII-7LXU5N7ZO5, NSC 269420, BRN 0840915, Neosemid, Zafurida, Chlor-N-(2-furylmethyl)-5-sulfamylanthranilsaeure [German], 5-(AMINOSULFONYL)-4-CHLORO-2-((2-FURYLMETHYL)AMINO)BENZOIC ACID, Furosemide, 4, Urex M, furosemide (lasix), Prestwick_752, Frumil (Salt/Mix), MFCD00010549, FUROSCIX, Furosemide [USAN:USP:INN:BAN:JAN], Spectrum_001100, 1z9y, FUROSEMIDE [MI], FUROSEMIDE [INN], FUROSEMIDE [JAN], Prestwick0_000341, Prestwick1_000341, Prestwick2_000341, Prestwick3_000341, Spectrum2_001005, Spectrum3_000437, Spectrum4_000560, Spectrum5_000744, FUROSEMIDE [HSDB], FUROSEMIDE [IARC], FUROSEMIDE [USAN], F0182, FUROSEMIDE [VANDF], UPCMLD-DP022, FUROSEMIDE [MART.], SCHEMBL9811, FUROSEMIDE [USP-RS], FUROSEMIDE [WHO-DD], FUROSEMIDE [WHO-IP], Oprea1_667724, BSPBio_000401, BSPBio_002054, KBioGR_001259, KBioSS_001580, 5-18-09-00555 (Beilstein Handbook Reference), MLS001066374, MLS001306403, MLS002548896, BIDD:GT0139, DivK1c_000575, SPECTRUM1500310, SPBio_001129, SPBio_002322, BPBio1_000443, Furosemide (JP17/USP/INN), GTPL4839, FUROSEMIDE [GREEN BOOK], FUROSEMIDE [ORANGE BOOK], UPCMLD-DP022:001, BDBM25902, HMS501M17, KBio1_000575, KBio2_001580, KBio2_004148, KBio2_006716, KBio3_001274, 4-chloro-2-(2-furylmethylamino)-5-sulfamoyl-benzoic acid, 4-chloro-2-[(2-furylmethyl)amino]-5-sulfamoylbenzoic acid, FUROSEMIDE [EP MONOGRAPH], NINDS_000575, FUROSEMIDE [USP MONOGRAPH], HMS1569E03, HMS1920B03, HMS2090K06, HMS2091H05, HMS2096E03, HMS2233H03, HMS3259M03, HMS3370J22, HMS3655E09, HMS3713E03, HMS3874G03, Pharmakon1600-01500310, FUROSEMIDUM [WHO-IP LATIN], ALBB-019200, HY-B0135, Tox21_110322, Tox21_202213, Tox21_302971, BBL027780, CCG-40223, NSC269420, NSC757039, STK177334, WLN: T5OJ B1MR CG FVQ DSZW, AKOS000266625, Tox21_110322_1, BCP9000708, CS-1915, DB00695, KS-1226, NC00453, NSC-757039, IDI1_000575, SMP1_000129, NCGC00016241-01, NCGC00016241-02, NCGC00016241-03, NCGC00016241-04, NCGC00016241-05, NCGC00016241-07, NCGC00016241-08, NCGC00016241-10, NCGC00016241-11, NCGC00090893-01, NCGC00090893-02, NCGC00090893-03, NCGC00090893-05, NCGC00090893-06, NCGC00256523-01, NCGC00259762-01, AC-11067, BF166384, BP-13261, SBI-0051389.P003, DB-052536, AB00052001, SW196894-3, C07017, D00331, D87719, EN300-126738, AB00052001-10, AB00052001-11, AB00052001_12, AB00052001_13, A830094, Q388801, SR-01000765380-2, SR-01000765380-3, SR-01000765380-7, BRD-K78010432-001-05-8, BRD-K78010432-001-10-8, Z275128584, 4-chloro-2-(2-furanylmethylamino)-5-sulfamoylbenzoic acid, Furosemide, British Pharmacopoeia (BP) Reference Standard, Furosemide, European Pharmacopoeia (EP) Reference Standard, 4-chloranyl-2-(furan-2-ylmethylamino)-5-sulfamoyl-benzoic acid, Furosemide, United States Pharmacopeia (USP) Reference Standard, 4-CHLORO-N-FURFURYL-5-SULFAMOYLANTHRANILIC ACID Furosemide, 5-(Aminosulfamyl)-4-chloro-2-[(2-furanylmethyl)amino]benzoic acid, 5-(Aminosulfonyl)-4-chloro-2-[(2-furylmethyl)amino]benzoic acid #, Furosemide, Pharmaceutical Secondary Standard; Certified Reference Material, Furosemide for peak identification, European Pharmacopoeia (EP) Reference Standard
Pubchem:PUBCHEM:3440
Id:1731e273-fc45-54b1-9226-e3c01fe33926
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View furosemide's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for furosemide.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with furosemide.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.